• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胰岛素原几种裂解形式(转化中间体)的受体结合及生物学活性。在培养的IM-9淋巴细胞中以及在大鼠体内和体外的研究。

Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.

作者信息

Peavy D E, Brunner M R, Duckworth W C, Hooker C S, Frank B H

出版信息

J Biol Chem. 1985 Nov 15;260(26):13989-94.

PMID:4055768
Abstract

The biological activities of several derivatives of human proinsulin (HPI) containing peptide bond cleavages or peptide deletions in the connecting peptide region were examined in vivo in rats and in several in vitro systems. The two derivatives which were tested in vivo, split (32-33)HPI and des-(64,65)HPI, both demonstrated greater potency in lowering blood glucose than did intact HPI. The receptor binding affinities of split (65-66)HPI, des-(57-65)HPI, des-(64,65)HPI, des-(33-56)HPI, des-(31,32)HPI, split (32-33)HPI, and split (56-57)HPI were examined in cultured IM-9 lymphocytes, freshly isolated rat adipocytes, and purified rat liver membranes and were compared to the binding of intact HPI and insulin. In these systems, HPI averaged approximately 1% of the activity of insulin. Modification of proinsulin in the connecting peptide region near the A-chain of insulin to form split (65-66)HPI, des-(57-65)HPI, des-(64,65)HPI, or des-(33-56)HPI resulted in an increase in affinity for receptor binding ranging from 11 to 27-fold over that of intact HPI. In contrast, modifications near the B-chain of insulin to form either des-(31,32)HPI or split (32-33)HPI resulted in roughly a 5-fold increase in affinity, whereas a cleavage within the connecting peptide to form split (56-57)HPI showed only a 2-fold increase in affinity as compared to intact HPI. The biological potencies of these materials were examined in isolated rat adipocytes. At high concentrations (10(-7) M), each derivative produced the same maximal response. At lower concentrations, differences in the relative potencies paralleled the differences in receptor binding affinity previously noted.

摘要

在大鼠体内以及多个体外系统中,对人胰岛素原(HPI)在连接肽区域含有肽键裂解或肽缺失的几种衍生物的生物活性进行了检测。在体内进行测试的两种衍生物,裂解(32 - 33)HPI和去(64,65)HPI,在降低血糖方面均显示出比完整HPI更强的效力。在培养的IM - 9淋巴细胞、新鲜分离的大鼠脂肪细胞和纯化的大鼠肝膜中检测了裂解(65 - 66)HPI、去(57 - 65)HPI、去(64,65)HPI、去(33 - 56)HPI、去(31,32)HPI、裂解(32 - 33)HPI和裂解(56 - 57)HPI的受体结合亲和力,并与完整HPI和胰岛素的结合情况进行了比较。在这些系统中,HPI的活性平均约为胰岛素的1%。胰岛素原在靠近胰岛素A链的连接肽区域进行修饰形成裂解(65 - 66)HPI、去(57 - 65)HPI、去(64,65)HPI或去(33 - 56)HPI后,与完整HPI相比,受体结合亲和力增加了11至27倍。相比之下,在胰岛素B链附近进行修饰形成去(31,32)HPI或裂解(32 - 33)HPI,亲和力增加了约5倍,而连接肽内的裂解形成裂解(56 - 57)HPI,与完整HPI相比,亲和力仅增加了2倍。在分离的大鼠脂肪细胞中检测了这些物质的生物效力。在高浓度(10⁻⁷ M)下,每种衍生物产生相同的最大反应。在较低浓度下,相对效力的差异与先前观察到的受体结合亲和力差异平行。

相似文献

1
Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.人胰岛素原几种裂解形式(转化中间体)的受体结合及生物学活性。在培养的IM-9淋巴细胞中以及在大鼠体内和体外的研究。
J Biol Chem. 1985 Nov 15;260(26):13989-94.
2
Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites.静脉注射人胰岛素原及其代谢产物的降血糖效力和代谢清除率。
Endocrinology. 1990 Nov;127(5):2418-22. doi: 10.1210/endo-127-5-2418.
3
In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes.生物合成人胰岛素原的体外活性。胰岛素原和胰岛素在分离的大鼠脂肪细胞中的受体结合及生物学效能。
Diabetes. 1984 Nov;33(11):1062-7. doi: 10.2337/diab.33.11.1062.
4
Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.重组基因技术生产的生物合成人胰岛素和微型胰岛素原的受体结合及生物活性
Diabetes Res Clin Pract. 1989 Jun 20;7(1):25-8. doi: 10.1016/0168-8227(89)90040-5.
5
Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.吸附于分离的大鼠脂肪细胞的胶原酶蛋白酶将生物合成的人胰岛素原转化为部分裂解的中间体。
Biochem J. 1988 Oct 1;255(1):277-84.
6
Biochemical and clinical implications of proinsulin conversion intermediates.胰岛素原转化中间体的生化及临床意义
J Clin Invest. 1985 Oct;76(4):1398-405. doi: 10.1172/JCI112116.
7
Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.胰岛素分泌颗粒II型内肽酶对去31,32-胰岛素原的切割优先于完整胰岛素原。这暗示了前激素加工的一条有利途径。
J Biol Chem. 1992 Nov 15;267(32):22719-27.
8
High affinity binding sites for proinsulin in human IM-9 lymphoblasts.人IM-9淋巴母细胞中胰岛素原的高亲和力结合位点。
Diabetologia. 1996 Apr;39(4):421-32. doi: 10.1007/BF00400673.
9
Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience.生物合成人胰岛素原。化学、体外和体内受体结合、动物和人类药理学研究以及临床试验经验综述。
Diabetes Care. 1992 May;15(5):666-92. doi: 10.2337/diacare.15.5.666.
10
Kinetics of biosynthetic human proinsulin action in isolated rat adipocytes.生物合成的人胰岛素原在分离的大鼠脂肪细胞中的作用动力学
Diabetes. 1986 Mar;35(3):318-23. doi: 10.2337/diab.35.3.318.

引用本文的文献

1
Development for Probiotics Based Insulin Delivery System.基于益生菌的胰岛素递送系统的研发。
Curr Issues Mol Biol. 2025 Feb 21;47(3):137. doi: 10.3390/cimb47030137.
2
Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics.精准医学和大数据时代的胰岛素认识:基因组学的未探索本质。
Biomolecules. 2023 Jan 30;13(2):257. doi: 10.3390/biom13020257.
3
Insulin Null β-cells Have a Prohormone Processing Defect That Is Not Reversed by AAV Rescue of Proinsulin Expression.胰岛素缺失β细胞存在前激素处理缺陷,该缺陷不能通过腺相关病毒拯救胰岛素原表达来逆转。
Endocrinology. 2022 Jun 1;163(6). doi: 10.1210/endocr/bqac051.
4
A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor.一种病毒衍生的胰岛素样肽是一种天然的人 IGF-1 受体竞争性拮抗剂。
Mol Metab. 2021 Nov;53:101316. doi: 10.1016/j.molmet.2021.101316. Epub 2021 Aug 13.
5
Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin.胰岛素自身免疫综合征(Hirata 病)中由于高分子量胰岛素原导致的 C-肽免疫反应性增加。
Clin Chem. 2021 Jun 1;67(6):854-862. doi: 10.1093/clinchem/hvab043.
6
Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications.活性超稳定单链胰岛素类似物的设计:合成、结构及治疗意义
J Biol Chem. 2008 May 23;283(21):14703-16. doi: 10.1074/jbc.M800313200. Epub 2008 Mar 10.
7
Human insulin production from a novel mini-proinsulin which has high receptor-binding activity.源自具有高受体结合活性的新型微型胰岛素原的人胰岛素生产。
Biochem J. 1998 Feb 1;329 ( Pt 3)(Pt 3):631-5. doi: 10.1042/bj3290631.
8
Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus.通过重组腺病毒过表达内肽酶PC2或PC3后,大鼠胰岛素瘤细胞系INS中的胰岛素原加工过程。
Biochem J. 1996 Nov 15;320 ( Pt 1)(Pt 1):11-5. doi: 10.1042/bj3200011.
9
Use of specific immunoradiometric assay to determine preterm neonatal insulin-glucose relations.使用特定免疫放射分析来确定早产新生儿胰岛素与葡萄糖的关系。
Arch Dis Child Fetal Neonatal Ed. 1995 Nov;73(3):F166-9. doi: 10.1136/fn.73.3.f166.
10
The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants.胰腺胰岛素分泌在新生儿糖调节中的作用。I. 足月健康和早产健康婴儿。
Arch Dis Child. 1993 Mar;68(3 Spec No):274-9. doi: 10.1136/adc.68.3_spec_no.274.